Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Leuk Res. 2019 Jan 7;77:42–50. doi: 10.1016/j.leukres.2018.11.010

Table 2.

Statistical Summary of AML Patients’ Predicted Response to BET Inhibitor JQ1.

Sensitivity Specificity PPV NPV Accuracy
BET Inhibitor (JQ1) 96.67%
(95% CI: 92.2999.33)
64.29%
(95% CI: 42.3681.51)
94.38%
(95% CI: 87.3798.15)
81.82%
(95% CI: 48.2297.72)
93.00%